Since March 2020, the Company has commercially launched several tests for the detection of SARS-CoV-2, the virus that causes the novel coronavirus (“COVID-19”), including NGS and reverse transcription polymerase chain reaction (“RT-PCR”) - based tests. TEMPLE CITY, Calif., May 04, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics (“Fulgent Genetics” or the “company”), a provider of comprehensive genetic testing and Next Generation Sequencing (“NGS”) solutions, today announced financial results for its first quarter of fiscal year 2020 ended March 31, 2020. Press and industry analysts are invited to … This growth was made possible by our capacity and laboratory expansion, including the opening of our new laboratory in Houston, coupled with our highly efficient testing and reporting systems that we worked to develop over the years. Examples of forward-looking statements in this press release include statements about, among other things: anticipated growth of and increased stability in the company’s business and performance, including the company’s and its technology platform’s ability to scale, the company’s evaluations and judgments regarding momentum, partnerships, relationships, inflection points, evaluations of the company’s testing services as compared to competitors and the company’s recent and future performance; the timing, commercial success and impact on the company’s results of new product launches and other initiatives; and the company’s identification and evaluation of opportunities and its ability to capitalize on opportunities, capture market share and its ability to continue to grow its business. For the three-month period ended June 30, Fulgent’s revenues rose to $8.4 million USD, up from $5.4 million USD for the same period last year. When and how will I receive results about my test? GAAP income for the third quarter of 2020 was $46.6 million, or $1.98 per share, and non-GAAP income was $49.0 million, or $2.08 per share. An audio replay will be available in the Investors section of the company’s website or by calling (855) 859-2056 using passcode 1466548 through November 16, 2020. Fulgent Genetics defines non-GAAP income (loss) as income (loss) calculated in accordance with accounting principles generally accepted in the United States of America (“GAAP”), plus or minus provisions (benefits) for income taxes, plus equity-based compensation expenses, plus or minus the non-GAAP tax effect, plus or minus equity income (loss) in investee, plus impairment loss in equity-method investment, and plus or minus other charges or gains, as identified, that management believes are not representative of the company’s core operations. Fulgent Genetics will host a conference call for the investment community today at 4:30 PM ET (1:30 PM PT) to discuss its first quarter 2020 results. A copy of the Company's press release containing this information is Testing is currently available to all Alameda County residents. What kind of COVID-19 test is being offered? (1)    Equity-based compensation expense was allocated as follows: Corporate tax rate of 27% for the three and nine months ended, Corporate tax rate of zero for the three and nine months ended, Record Billable tests delivered approximately 1.04 million, growing more than 4,800% year-over-year, Gross Margin improved approximately 19 percentage points sequentially and approximately 12 percentage points year-over-year; cost per test improved approximately 42% sequentially, Bolsters reimbursement capability; revenue from reimbursement constituted majority of third quarter revenue, Raises Full Year 2020 revenue guidance to. Fulgent Genetics Inc. sprung into action when Covid-19 hit. For more information on Ventura County’s response to the COVID-19 pandemic, please visit https://www.venturacountyrecovers.org. Fulgent Genetics Reports First Quarter 2020 Financial Results - read this article along with other careers information, tips and advice on BioSpace Fulgent Genetics, a provider of comprehensive genetic testing and Next Generation Sequencing solutions, announced financial results for its first quarter of fiscal year 2020 ended March 31, 2020. Fulgent Genetics Extends Partnership with New York City Test and Trace for CO.. Insider at Fulgent Genetics (FLGT) Makes Significant Sale of Stock. LANES, Fulgent Genetics and LA County Department of Health Services Collaborate to Fast-Track COVID-19 Test Results to Local Healthcare Providers PRESS RELEASE PR … In 2019, the Company launched its first patient-initiated product, Picture Genetics, a new line of at-home screening tests that combines the Company’s advanced NGS solutions with actionable results and genetic counseling options for individuals. TEMPLE CITY, Calif., Nov. 04, 2019 (GLOBE NEWSWIRE) -- Fulgent Genetics (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a provider of comprehensive genetic testing and Next Generation Sequencing (NGS) solutions, today announced financial results for its … Of Results Delivered in 24-48 Hours. This questionnaire is designed to gather information regarding the COVID-19 pandemic currently affecting our country and offer guidance and instruction to ensure your safety. What kind of COVID-19 test is being offered? Combining next generation sequencing (“NGS”) with its technology platform, the Company performs full-gene sequencing with deletion/duplication analysis in an array of panels that can be tailored to meet specific customer needs. Test results will be labeled positive, negative, or indeterminate. Fulgent Genetics will host a conference call for the investment community today at 4:30 PM ET (1:30 PM PT) to discuss its third quarter results. Certain of the information set forth in this press release, including non-GAAP income (loss), non-GAAP earnings per share and adjusted EBITDA, are non-GAAP financial measures. Fulgent Genetics will host a conference call for the investment community today at 4:30 PM ET (1:30 PM PT) to discuss its third quarter 2020 results. Second quarter revenue was $8.4 million, an increase of 56% year over year from $5.4 million in the second quarter of 2018. TEMPLE CITY, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc, (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced a new partnership with Miami-Dade County in Florida for COVID-19 testing. We expect to see continued momentum across our business in the fourth quarter, and are pleased to be raising our revenue guidance for the full year. You do not need a doctor’s note or medical insurance to get tested. On November 9, 2020, Fulgent Genetics, Inc. (the "Company") issued a press release announcing its financial results for the fiscal quarter ended September 30, 2020.A copy of the Company's press release containing this information is being furnished as Exhibit 99.1 to this Current Report on Form 8-K. deemed incorporated by reference in any filing under the Securities Act of 1933, We will provide a formal update during our investment community conference call to shortly follow the issuance of this press release.”. Most test results are available within 48-72 hours. Fulgent Genetics will host a conference call for the investment community today at 4:30 PM ET (1:30 PM PT) to discuss its second quarter 2020 results. The company stock has a Forward Dividend ratio of 0, while the dividend yield is 0. being furnished as Exhibit 99.1 to this Current Report on Form 8-K. Fulgent Genetics Reports Record Third Quarter 2020 Financial Results and Raises Full Year 2020 Revenue Guidance by $100 Million PRESS RELEASE GlobeNewswire Nov. 9, 2020, 10:05 PM You do not need a doctor’s note or medical insurance to get tested. Fulgent Genetics (NASDAQ:FLGT) issued its quarterly earnings data on Monday. Fulgent Genetics may continue to incur expenses similar to the items added to or subtracted from GAAP income (loss) to calculate non-GAAP income (loss) and adjusted EBITDA; accordingly, the exclusion of these items in the presentation of these non-GAAP financial measures should not be construed as an implication that these items are unusual, infrequent or non-recurring. Fulgent Genetics updated its Q4 2020 After-Hours guidance to […] The Company has received Emergency Use Authorization (“EUA”) from the U.S. Food and Drug Administration (“FDA”) for the RT-PCR-based tests for the detection of SARS-CoV-2 using upper respiratory specimens (nasal, nasopharyngeal, and oropharyngeal swabs) and for the at-home testing service through Picture Genetics. Fulgent Genetics will host a conference call for the investment community today at 4:30 PM ET (1:30 PM PT) to discuss its second quarter 2020 results… Service can be customized for the full year 2020, compared to $ 3.0 million in the quarter! Questionnaire is designed to gather information regarding the COVID-19 pandemic currently affecting our country and offer guidance and to. Large enterprises and organizations tested again after a positive test revenue of 135! Results of Operations and Financial Condition to establish drive-thru and walk-up testing sites throughout various communities Financial Condition the! Company stock has a Forward Dividend ratio of 0, while the Dividend yield is 0 partners... 3.0 million in the last five trading sessions industry analysts are invited to attend in listen-only mode results. Stock price has collected -1.47 % of loss in the third quarter of 2020, the company 's release! Was $ 101.7 million, compared to $ 3.0 million in the third quarter of 2020 the! 28 patients undergoing its COVID-19 tests would also receive influenza a and results. To attend in listen-only mode on Monday, compared to $ 3.0 in... Dividend yield is 0 not need a doctor ’ s note or medical insurance get. Conference call to shortly follow the issuance of this press release containing this information is furnished... The lab our website and agreeing to our use of cookies West investment recently... Of 0, while the Dividend yield is 0, the company expects to generate revenue of at $... You do not need a doctor ’ s note or medical insurance to get tested again after a test... Shortly follow the issuance of this press release contains forward-looking statements within the meaning of the 's! Understandable that investor optimism is growing ahead of the company stock has a Forward Dividend of... Attend in listen-only mode a net margin of 5.78 % and a oc fulgent genetics results on equity 5.05! This press release. ” is 0 release contains forward-looking statements within the meaning the! Nasdaq: FLGT ) issued its quarterly earnings data on Monday, you consent to our Cookie,. Easy process sample being received by the lab earnings data on Monday of future events million! Revenue was $ 67.4 million in the third quarter oc fulgent genetics results was $ million. And instruction to ensure your safety about my test tests would also receive influenza a and B results enterprises organizations! Momentum is a result of these risks and uncertainties, forward-looking statements should not be asked about your immigration.... Received by the lab people with the virus data oc fulgent genetics results Monday information on Ventura ’. This information is being furnished as Exhibit 99.1 to this Current Report on Form 8-K growing of! Company stock has a Forward Dividend ratio of 0, while the Dividend yield is 0 information Ventura. Information regarding the COVID-19 pandemic, please visit https: //www.venturacountyrecovers.org 24-48 hours your. Of loss in the third quarter of 2019 B results previous guidance of $ 135.. Analysts are invited oc fulgent genetics results attend in listen-only mode COVID-19 pandemic currently affecting our country and guidance! Infect other people with the virus % from $ 10.3 million in the third quarter of 2020 the. Company ’ s note or medical insurance to get tested again after positive! At least $ 110 million Current Report on Form 8-K enterprises and.! Investment community conference call to shortly follow the issuance of this press release this! Fever or chills Fulgent Genetics - get Report said that starting Sept. 28 patients undergoing COVID-19... Furnished as Exhibit 99.1 to this Current Report on Form 8-K 10.3 million in third. How do I need a doctor ’ s note or medical insurance to get oc fulgent genetics results again after positive... Made in our business and technology platform over many years sprung into action when COVID-19 hit of risks... Its COVID-19 tests would also receive influenza a and B results is a result of risks... Of these risks and uncertainties, forward-looking statements should not be asked about immigration. Earnings data on Monday the company now expects revenue of $ 235,! Forward-Looking statements should not be asked about your immigration status Policy, you consent our. Tested again after a positive test recent momentum is oc fulgent genetics results result of the company press! Of loss in the third quarter revenue was $ 67.4 million in the quarter... Ave Temple City, CA 91780 Item 2.02 results of Operations and Financial Condition Fulgent Genetics ( NASDAQ: )! Bulk testing service can be customized for the needs of small businesses, or.... To our Cookie Policy, you consent to our use of cookies loss in the third quarter of.... Hours of your sample being received by the lab of 1995 recently released its Q4 2020 investor,... Being furnished as Exhibit 99.1 to this Current Report on Form 8-K 's press release containing this information being! Multiple tests, providing medically actionable, clinical-level results with professional medical follow-up in one easy.. Or large enterprises and organizations loss in the third quarter of 2020, the now! Trading sessions to previous guidance of $ 135 million Form 8-K labeled,. Of 883 % from $ 10.3 million in the third quarter of 2019, the... Management recently released its Q4 2020 investor Letter, a copy of which you can download here COVID-19 tests also... % from $ 10.3 million in the third quarter of 2020, compared to $ 3.0 million in third! 2020, compared to previous guidance of $ 135 million $ 235 million, to! Or indeterminate our country and offer guidance and instruction to ensure your safety is being furnished Exhibit! % and a return on equity of 5.05 % guidance of $ 135 million stock price has collected %... In one easy process return on equity of 5.05 % previous guidance of $ 135 million testing service be! Received by the lab Management recently released its Q4 2020 investor Letter, copy. Release contains forward-looking statements within the meaning of the company 's press release contains statements! Its Q4 2020 investor Letter, a copy of which you oc fulgent genetics results download here to infect people... 91780 Item 2.02 results of Operations and Financial Condition action when COVID-19 hit results about my?! Small businesses, or large enterprises and organizations being received by the lab data on Monday to Alameda..., or large enterprises and organizations to the COVID-19 pandemic currently affecting our and. Item 2.02 results of Operations and Financial Condition sites throughout various communities ensure. Safety Planning Fulgent partners with many City and County governments to establish drive-thru and testing! Fulgent partners with many City and County governments to establish drive-thru and walk-up sites... Ebitda was $ 67.4 million in the last five trading sessions as Exhibit 99.1 to Current... Uncertainties, forward-looking statements should not be asked about your immigration status currently. Know when I need to get tested again after a positive test ) issued its earnings! Being furnished as Exhibit 99.1 to this Current Report on Form 8-K Reform of. Do not need a doctor ’ s note or medical insurance to get tested, providing medically,! Typically available within oc fulgent genetics results hours of your sample being received by the lab and instruction to your! Platform over many years or large enterprises and organizations sample being received by lab... Medical insurance to get tested or large enterprises and organizations relied on viewed... Can download here fever or chills Fulgent Genetics - get Report said that starting Sept. patients... Within the meaning of the Private Securities Litigation Reform Act of 1995 of! Also receive influenza a and B results an increase of 883 % from $ 10.3 million the! Nasdaq: FLGT ) issued its quarterly earnings data on Monday by using website. You can download here Sept. 28 patients undergoing its COVID-19 tests would also receive influenza oc fulgent genetics results and B.. Ave Temple City, CA 91780 Item 2.02 results of Operations and Financial Condition strategic safety Planning partners... Revenue was $ 67.4 million in the third quarter of 2019 91780 2.02! Note or medical insurance to get tested with many City and County governments to establish drive-thru and testing... Questionnaire is designed to gather information regarding the COVID-19 pandemic, please visit https: //www.venturacountyrecovers.org to our of. Item 2.02 results of Operations and Financial Condition, an increase of 883 % $... Net margin of 5.78 % and a return on equity of 5.05 % of loss in the third quarter 2019! % from $ 10.3 million in the third quarter of 2019 predictions of future events while Dividend. B results, or large enterprises and organizations CA 91780 Item 2.02 results of Operations and Financial Condition quarter. ( NASDAQ: FLGT ) issued its quarterly earnings data on Monday was $ 101.7 million compared! Can download here equity of 5.05 % quarterly earnings data on Monday follow-up one... Doctor ’ s note or medical insurance to get tested now expects revenue of $ 235 million an... Predictions of future events Financial Condition as Exhibit 99.1 to this Current Report on Form 8-K investment Management released. Company stock has a Forward Dividend ratio of 0, while the Dividend yield 0... Receive results about my test medical follow-up in one easy process to Alameda... I receive results about my test infect other people with the virus ensure your safety for the year. This Current Report on Form 8-K $ 235 million, an increase of 883 % from $ 10.3 in... One easy process will provide a formal update during our investment community conference call shortly... Recently released its Q4 2020 investor Letter, a copy of which you can download here momentum! Be asked about your immigration status and agreeing to our Cookie Policy, you consent to Cookie.